Topic: MedTech

Dive Brief: The National Evaluation System for health Technology (NESTcc) is seeking feedback on plans to add […]

Global health IT provider Royal Philips has launched a slew of products this week at HIMSS’ annual healthcare conference in Las Vegas.

The diagnostic software runs on Lunit’s AI technology to spot major abnormal findings.

Stryker (NYSE:SYK) announced today that it launched its next-generation SurgiCount + safety-sponge system.Kalamazoo, Mich.-based Stryker […]

Tiny and precise, smarter 6DOF wire-winding technologies can increase surgical access and improve outcomes. Minimally […]

As the effects of the COVID-19 pandemic continue, Daniel Sciubba (New York, USA), discusses how […]

Boston Scientific (NYSE:BSX) announced today that it received FDA 510(k) clearance for its Exalt Model B […]

The US Food and Drug Administration (FDA) has granted 510(k) approval for STAGE (STrategically Acquired […]

Here’s why medtech companies must embrace innovation, connectivity and disruption. DeviceTalks Healthcare must shift away […]

Nanox Imaging said it would acquire Zebra Medical Vision for $100 million with a potential for $100 million in milestone payments. The company will also acquire USARAD for $30 million.

Shockwave Medical (NSDQ:SWAV) shares ticked up today on second-quarter results that topped the consensus forecast. The […]

The medtech industry has been rising for weeks and the latest seven-day stretch was no […]

Intuitive Surgical (NASDAQ: ISRG) will spend more than $500 million to expand its Peachtree Corners […]

VenoValve has the potential to offer relief for patients that suffer from severe chronic venous insufficiency (CVI) in the deep veins of their legs.

The trial is the first study to compare interventional therapy in combination with anticoagulation vs. anticoagulation alone for pulmonary embolism.

Beacon MedTech Solutions — formerly Built Rite-Reliance and LSR Engineering — recently announced that it has […]

The proceeds will enable the company to complete development and perform its first clinical trial.

The artificial intelligence-based technology of Iterative Scopes brings computer vision analysis to endoscopic images. The startup’s technology was initially developed to assist gastroenterologists in finding pre-cancerous polyps but CEO and founder Jonathan Ng said it’s also finding additional use helping pharmaceutical companies identify patients for clinical trials.

Tegra Medical announced that it appointed Darren Vine as its director of sales and marketing […]

Olympus recently announced its SeleCT Connect program, which uses diagnostic imaging AI to automatically screen […]

Zimmer Biomet (NYSE:ZBH) shares slid before hours on second-quarter results that topped the consensus forecast. The […]

Abbott (NYSE:ABT) announced today that it received FDA clearance for its FreeStyle Libre 2 iOS […]

Philips, Endologix and several smaller companies in recent weeks won the regulatory privilege, giving them speedier review of products that may provide more effective treatments for life-threatening conditions.

NuVasive has announced that it has received US Food and Drug Administration 510(k) clearance for […]

Smith+Nephew (LON: SN; NYSE: SNN) saw its sales jump 48% in Q2, with the company reiterating […]

The medtech industry remains on the upswing as companies see their stocks rising with quarterly […]

TransMedics (NSDQ:TMDX) has won FDA clearance of its OCS Lung System to provide hypothermic flushing, storage […]

Align Technology (NSDQ:ALGN) shares shot up today on second-quarter results that came in ahead of the […]

Edwards Lifesciences (NYSE: EW) reported second-quarter results this evening that beat the consensus forecast on Wall […]

Abbott (NYSE:ABT) announced that it launched the Jot Dx — its latest insertable cardiac monitor (ICM) […]

Dexcom (NSDQ:DXCM) shares ticked up after hours on second-quarter results that topped the consensus forecast. The […]

The financing will fund the commercialization of the company’s handheld ultrasound device and its intuitive point-of-care ultrasound workflow solution, Exo Works.

Neuro42, a US medical technology start-up focused on magnetic resonance imaging (MRI) and robotics, has […]

MedRhythms is developing prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease.

The company hopes this study will be a stepping stone towards regulatory approval of its product. 

The company will grow its services nationwide with the new cash.

Orthofix (NSDQ:OFIX) today announced that it has launched its FiberFuse Strip bone graft in the U.S. […]

Asensus Surgical (NYSE American: ASXC) announced today that FDA has cleared 5 mm diameter articulating instruments […]

Medtronic (NYSE:MDT) announced today that the FDA cleared two of its AccuRhythm AI algorithms for use […]